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The precise role of erythropoietin receptor–activated (EpoR-activated) 
Stat5 in the regulation of erythropoiesis remains unclear. In this issue 
of the JCI, Menon and colleagues present new experimental data that 
indicate a distinct role for Stat5 in the regulation of stress-induced 
erythropoiesis, such as during acute anemic states (see the related article 
beginning on page 683). A critical function for Stat5 is to promote cell 
survival, possibly through transcriptional induction of the antiapop-
totic protein Bcl-x. In the present experimental system, erythropoietin-
Stat5 signals did not induce Bcl-x expression but did induce oncostatin-
M. Moreover, oncostatin-M was found to enhance survival of erythroid 
progenitors. This work differentiates between steady-state (or homeo-
static) erythropoiesis and stress-induced erythropoiesis at the level of 
EpoR signaling.
In adults, red blood cell production by 
bone marrow progenitors maintains the 
steady-state level of circulating cells. But 
during times of “stress,” such as acute 
anemia, the erythropoietic response is pre-
dominantly generated by hematopoietic 
progenitors residing in the spleen, at least 
in mice. In both circumstances, erythropoi-
etin (Epo) and SCF are the central regula-
tors, albeit that compensatory circulating 
Epo levels are higher during recovery from 
acute anemia. The study of developmen-
tal hematopoiesis has revealed that fetal 
erythropoiesis and adult erythropoiesis 
occur in distinct anatomic sites and with 
distinct regulatory features (1, 2), and 
it has been suggested that adult splenic 
erythropoiesis more closely approximates 
fetal liver erythropoiesis than adult bone 
marrow erythropoiesis. Do these differ-
ences between steady-state erythropoietic 
regulation and the stress-induced erythro-
poietic response reflect differences in the 
erythroid progenitors in adult bone mar-
row versus spleen, differences in Epo/SCF 
signaling, the activity of other cytokines, 
or differences in the tissue microenviron-
ment? In this issue of the JCI, Menon and 
coworkers provide evidence implicating the 
Epo receptor–activated (EpoR-activated) 
Stat5 signal as a unique contributor to the 
stress-induced erythropoietic response and 
thereby distinguishing homeostatic and 
stress-induced erythropoiesis at the level 
of EpoR signaling (3).
4UBUBDUJWBUJPOJTSFRVJSFE
GPSUIFTUSFTTJOEVDFE
FSZUISPQPJFUJDSFTQPOTF
Following engagement of the EpoR, the 
preassociated tyrosine kinase Jak2 is acti-
vated, which then mediates phosphory-
lation of 8 conserved tyrosine motifs to 
generate phosphotyrosine (PY) recogni-
tion sites within the cytoplasmic tail of 
the EpoR (Figure 1). These PY sites serve 
to recruit both positive and negative regu-
lators that effect erythroid progenitor 
expansion through both prosurvival and 
proliferative signals. The most proximal 
PY site, Y343, serves to recruit and acti-
vate Stat5; however, the role of Stat5 in 
the regulation of erythropoiesis remains 
controversial (4–8). Menon et al. (3) used 
genetically engineered mice, developed in 
the laboratory of James N. Ihle (St. Jude 
Children’s Research Hospital, Memphis, 
Tennessee, USA), that express a truncated 
form of the EpoR containing the single 
Stat5-interacting tyrosine residue Y343 
(EpoR-H mice) or express a similarly trun-
cated EpoR that is tyrosine null (Y343F) 
(EpoR-HM mice) (8). Since these mutants 
were knocked in to the EpoR gene locus, 
this allows for physiologic mutant recep-
tor expression in appropriate tissues and 
cells, in the absence of endogenous WT 
receptor expression. These mice were sub-
jected to 3 stress conditions: phenylhy-
drazine-induced acute hemolytic anemia, 
acute anemia secondary to 5-fluorouracil–
induced reduction in number of maturing 
erythroid progenitors, and anemia follow-
Nonstandard abbreviations used: BMP, bone  
morphogenic protein; Epo, erythropoietin; EpoR,  
Epo receptor; EpoR-H mice, mice expressing a truncat-
ed form of the EpoR containing the single Stat5-inter-
acting tyrosine residue Y343; EpoR-HM mice,  
mice expressing a truncated form of the EpoR  
that is tyrosine null (Y343F); f, flexed-tail; PY,  
phosphotyrosine.
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ing bone marrow transplantation. In all 3 
instances, despite normal, steady-state 
levels of circulating erythrocytes, EpoR-
HM mice were incapable of appropriately 
responding to anemic stress, whereas 
EpoR-H mice responded in a manner 
similar to that of WT controls, suggesting 
that Stat5 is a critical regulator of stress-
induced erythropoiesis, but not steady-
state erythropoiesis (3). This is supported 
by the finding that some adult Stat5a,b–/– 
mice are also compromised in their 
response to phenylhydrazine-induced 
acute anemia (7). A potential limitation 
of the present study is whether removal 
of the distal cytoplasmic tail of the EpoR, 
which has been shown to function as a 
negative regulatory domain (9), might, in 
addition to Stat5, also contribute to the 
stress-induced erythropoietic response.
4UBUJOEVDFEPODPTUBUJO.CVUOPU
#DMYDPPQFSBUFTXJUI&QP4$'
If Stat5 signals are uniquely critical for 
stress-induced erythropoiesis, then what 
is the nature of this signal? The authors 
looked at the induction of a group of 
known Epo- and Stat5-responsive genes 
(3). WT EpoR– and EpoR-H–containing 
primary erythroid progenitors induced 
expression of Pim-1 kinase, oncostatin-M, 
and SOCS-3 (Figure 1), but, surprisingly, 
not Bcl-x, an antiapoptotic factor impor-
tant for red blood cell survival (10), whose 
expression has been reported to be either 
decreased (5, 7) or unaffected in Stat5a,b–/– 
mice (6). This result raises the possibil-
ity that factors other than, or in addi-
tion to, Bcl-x are important for the sur-
vival of developing red blood cells. Since 
oncostatin-M has been suggested to 
contribute to erythroblast survival (11), 
Menon et al. (3) asked whether oncostatin-
M signals cooperate with Epo/SCF signals 
to regulate erythropoiesis. Oncostatin-M 
treatment significantly enhanced the sur-
vival of EpoR-H bone marrow erythroid 
progenitors in ex vivo cultures, suggest-
ing the presence of a positive feedback 
loop whereby Epo induces oncostatin-M 
production and oncostatin-M positively 
modulates erythroid expansion (Figure 1). 
How Epo, SCF, and now oncostatin-M 
signals converge to effect erythroid expan-
sion and whether this is unique to stress-
induced erythropoiesis, in vivo, remain to 
be determined.
"SFCPOFNBSSPXBOETQMFOJD
FSZUISPJEQSPHFOJUPSTEJTUJODU 
Are EpoR-H signals unique to adult 
splenic progenitors? In other words, are 
adult splenic erythroid progenitors dis-
tinct from adult bone marrow erythroid 
progenitors? Apparently not, since ex vivo 
cultures of EpoR-HM adult bone mar-
row–derived erythroid progenitors also 
exhibited defects in Epo-induced prolif-
eration and evidence of increased apop-
tosis — defects rescued by restoration of 
the Stat5 PY site (3). But these analyses 
are, by their nature, performed out of bio-
logical context and thus do not account 
for potential differences in microenvi-
ronmental regulation. The recent reex-
amination of flexed-tail (f) mutant mice 
is particularly informative in this regard 
(12). Like Stat5a,b–/– and EpoR-HM mice, 
adult f/f mice exhibit normal steady-
state erythropoiesis but do not respond 
to acute erythropoietic stress. Mutant f/f 
mice have a mutation in the Madh5 gene, 
a functional Smad molecule downstream 
of bone morphogenic protein (BMP) 
receptor signaling (Figure 1). BMP4 is 
rapidly, and transiently, induced in the 
splenic red pulp (site of erythropoiesis) in 
response to acute anemia and was found 
to stimulate immature progenitors to 
give rise to Epo-responsive progenitors. 
Importantly, only spleen, not bone mar-
row, progenitors responded to BMP4 in 
ex vivo cultures. This result suggests that 
the spleen does indeed contain a unique 
erythropoietic microenvironment that 
may distinctly influence erythroid pro-
genitors present therein. Likely, BMP4 
expression will be induced in the spleen 
of both EpoR-HM and EpoR-H mice, 
since BMP4 transcription appears to be 
regulated by hypoxia-responsive elements 
(11). Whether immature, Epo-nonrespon-
sive splenic progenitors from EpoR-HM 
and EpoR-H mice differ in their response 
to BMP4 warrants testing, since BMP4 
can affect CNS stem cell fate in a pathway 
activating Stat3 (13).
Finally, studies such as that of Menon et 
al. (3) highlight the importance of study-
ing and disseminating genetically modi-
'JHVSF
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fied mice with minimal or no steady-state 
phenotype. In many ways these mice could 
be viewed as models for otherwise normal 
adult humans who exhibit exaggerated or 
unexpected responses to inflammation, 
infectious agents, or cancer progression. 
As such, they have the potential to identify 
and dissect regulatory pathways that influ-
ence but do not cause disease.
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The anaphylatoxins complement component 3a and 5a (C3a and C5a, respec-
tively) are classically seen as proinflammatory mediators of allergic asthma 
that recruit inflammatory cells, induce edema, and cause bronchoconstric-
tion. A few years ago, controversy arose when it was shown that C5-deficient 
mice were more susceptible to experimental asthma compared with C5-suf-
ficient mice. In a study by Köhl et al. in this issue of the JCI, it is shown 
in a series of truly “complementary” experiments that C5a receptor (C5aR) 
blockade promotes Th2 sensitization upon first exposure to inhaled aller-
gen, whereas C5aR blockade during established inflammation suppresses 
the cardinal features of asthma (see the related article beginning on page 
783). Blockade of C5aR alters the function of airway DCs, crucial for induc-
ing and maintaining Th2 responses in the lung. Targeting C5aR as a treat-
ment for established asthma could be beneficial, but might be accompanied 
by sensitization to novel antigens.
"MMFSHZJTNFEJBUFECZ5IDFMMT
The incidence of allergic diseases is cur-
rently on the rise. In western societies, 
up to 25% of children are sensitized to 
allergens such as the house dust mite 
(HDM), pollen, animal dander, or food 
components. This sensitization is indi-
cated clinically by the presence in the 
serum of allergen-specific IgE and by an 
immediate wheal and flare reaction after 
skin prick testing with these allergens. 
In most, but not all, sensitized individu-
als, natural allergen exposure via food or 
inhalation can lead to allergic diseases 
such as allergic asthma, allergic rhinitis, or 
atopic dermatitis. These diseases have an 
inflammatory component characterized 
by edema, plasma extravasation, accumu-
lation of eosinophils and mast cells, and 
overproduction of mucus (1, 2). In the case 
of allergic asthma, an additional symptom 
is airway hyperresponsiveness (AHR) to all 
kinds of specific and nonspecific stimuli, 
which is caused by excessive smooth mus-
cle contraction, resulting in airway nar-
rowing. Allergic sensitization is the result 
of an aberrant Th2 response to allergens. 
Th2 lymphocytes produce cytokines that 
control Ig-class switching toward IgE pro-
duction (e.g., IL-4), allergic eosinophilic 
inflammation (e.g., IL-5), and AHR (e.g., 
IL-9, IL-13). In support of a critical role for 
Th2 cells, experimental asthma does not 
develop in mice deficient in CD4 cells or 
most of the above cytokines (3).
5IFDPNQMFNFOUTZTUFNJOBTUINB
The complement system is crucial for 
innate host defense because of its forma-
tion of a lytic effector system that protects 
against pathogens. Serine proteases gener-
ated in response to classical and alterna-
tive activation of complement can cleave 
the anaphylatoxic peptides complement 
3a (C3a) and C5a from C3 and C5, respec-
tively (4). Various components of the com-
plement pathway have been implicated in 
mediating allergic inflammation (5, 6). 
First, the anaphylatoxins C3a and C5a are 
found in increasing concentrations in the 
bronchoalveolar lavage fluid of asthmat-
Nonstandard abbreviations used: AHR, airway hyper-
responsiveness; C3a, complement component 3a; C5aR, 
C5a receptor; CCL17, CC chemokine ligand 17; CCR4, 
CC chemokine receptor 4; HDM, house dust mite; 
mDC, myeloid DC; pDC, plasmacytoid DC.
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